Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Supply, Demand and Key Producers, 2026-2032
The global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market size is expected to reach $ 1218 million by 2032, rising at a market growth of 12.7% CAGR during the forecast period (2026-2032).
Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) refers to high-purity ?-NMN raw materials manufactured through biological fermentation, enzymatic catalysis, or chemical synthesis processes and used as core ingredients for longevity-related supplements, functional nutrition products, anti-aging formulations, and scientific research applications. NMN is a bioactive nucleotide derivative and a direct precursor of nicotinamide adenine dinucleotide (NAD+), a critical coenzyme involved in cellular energy metabolism, mitochondrial function, DNA repair, and aging-related biological pathways. The market scope covers NMN raw material products with different purity grades and manufacturing technologies, primarily including fermentation-based NMN, enzymatically synthesized NMN, and chemically synthesized NMN. The research focuses on commercial NMN raw material supply, production capacity, pricing structure, technology development, industrial chain, and downstream applications in health and longevity-related industries.
This report is a detailed and comprehensive analysis of the world market for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market
2. What is the demand of the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market?
3. What is the year over year growth of the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market?
4. What is the production and production value of the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market?
5. Who are the key producers in the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market?
6. What are the growth factors driving the market demand?
Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) refers to high-purity ?-NMN raw materials manufactured through biological fermentation, enzymatic catalysis, or chemical synthesis processes and used as core ingredients for longevity-related supplements, functional nutrition products, anti-aging formulations, and scientific research applications. NMN is a bioactive nucleotide derivative and a direct precursor of nicotinamide adenine dinucleotide (NAD+), a critical coenzyme involved in cellular energy metabolism, mitochondrial function, DNA repair, and aging-related biological pathways. The market scope covers NMN raw material products with different purity grades and manufacturing technologies, primarily including fermentation-based NMN, enzymatically synthesized NMN, and chemically synthesized NMN. The research focuses on commercial NMN raw material supply, production capacity, pricing structure, technology development, industrial chain, and downstream applications in health and longevity-related industries.
Key Findings
- Global NMN raw material output reached approximately 1,700 tons in 2024
- Global NMN production capacity exceeded approximately 2,100 tons in 2024
- Average NMN raw material price reached around US$300,000 per ton
- Industry average gross margin reached approximately 36%
- High-purity NMN dominates premium longevity applications
- China remains a major NMN raw material manufacturing base
Market Trends
The NMN raw material market is evolving from early-stage supplement commercialization toward a more technology-driven longevity health industry. Manufacturers are increasingly improving production efficiency through enzyme catalysis and fermentation technologies, which provide advantages in purity control, environmental performance, and scalability compared with traditional chemical synthesis routes. High-purity NMN products are becoming increasingly important as customers demand stronger quality assurance, traceability, and standardized production processes. At the application level, NMN is expanding beyond conventional dietary supplements into integrated longevity solutions combining metabolic health, healthy aging, and beauty-from-within concepts. Future market development will increasingly depend on production technology optimization, regulatory acceptance, clinical validation, and the establishment of reliable global supply chains.Market Dynamics
Drivers
The growth of the NMN raw material market is primarily driven by increasing global aging populations, rising consumer awareness of preventive healthcare, and growing demand for longevity-related nutrition products. Scientific interest surrounding NAD+ metabolism, cellular energy regulation, and aging mechanisms has accelerated commercial adoption of NMN ingredients. In addition, premium health consumers are increasingly willing to pay for high-quality anti-aging products, supporting demand for high-purity NMN raw materials.Restraints
The market faces limitations from evolving regulatory policies, differences in acceptance of NMN products across countries, and uncertainty regarding long-term clinical evidence. Production costs remain relatively high compared with conventional nutritional ingredients, particularly for high-purity NMN manufactured under strict quality standards. Regulatory classification differences between dietary supplements, functional foods, and pharmaceutical-related products may also influence commercialization strategies.Opportunities
Future opportunities are concentrated in high-quality NMN ingredient development, international expansion, and integration with broader longevity healthcare ecosystems. Advances in microbial fermentation and enzyme engineering may reduce production costs while improving consistency and scalability. Growing demand from premium nutrition brands, personalized health management platforms, and anti-aging beauty markets provides additional growth opportunities for NMN suppliers with strong manufacturing capabilities and quality certifications.Challenges
The NMN industry faces challenges related to regulatory uncertainty, competition among global ingredient suppliers, and the need for stronger scientific evidence supporting long-term health benefits. Companies must continuously improve manufacturing processes, maintain product purity, strengthen supply chain transparency, and differentiate themselves through technology and quality rather than relying only on price competition.Industry Chain Analysis
The NMN raw material industry chain consists of upstream raw materials, midstream NMN manufacturing, and downstream application markets. The upstream segment includes key inputs such as nicotinamide, ribose-related materials, enzymes, fermentation substrates, and biochemical processing materials. The midstream segment focuses on NMN production, purification, crystallization, quality testing, and commercial packaging. Manufacturers utilize fermentation, enzymatic catalysis, or chemical synthesis technologies to produce different purity grades of NMN raw materials. The downstream segment includes dietary supplement companies, functional food manufacturers, beauty and anti-aging product developers, and research institutions. Value creation mainly comes from production technology optimization, purity improvement, regulatory compliance, and brand-oriented application development.Value Chain Analysis
NMN value creation depends on the combination of biotechnology innovation, manufacturing capabilities, quality control systems, and downstream commercialization. Upstream biotechnology suppliers provide production-related enzymes and biological materials, while NMN manufacturers create differentiated value through process efficiency, purity level, and manufacturing scale. Downstream companies capture additional value through formulation development, branding, consumer education, and global distribution channels.Segment Insights
By manufacturing process, fermentation and enzymatic catalysis are becoming increasingly important technology directions because they offer better selectivity, lower environmental impact, and improved quality consistency. Chemical synthesis remains relevant due to established industrial experience but faces increasing pressure from cleaner biological production methods. By purity level, high-purity NMN products represent the premium segment and are widely used in high-end longevity supplements and specialty nutrition products, while lower-purity products mainly serve price-sensitive applications. By chemical structure, ?-NMN is the commercially dominant form because of its stronger market recognition and broader application acceptance, whereas ?-NMN remains mainly associated with research-oriented applications.Downstream Market Opportunities
Dietary supplements represent the largest downstream application area for NMN raw materials, supported by consumer demand for healthy aging and preventive wellness products. Functional foods and beauty anti-aging products are emerging application opportunities as brands integrate NMN into broader metabolic health and skin health solutions. The expansion of longevity-focused healthcare concepts is expected to create additional demand from premium nutrition companies and personalized health management platforms.Regional Insights
Asia-Pacific represents the leading manufacturing region for NMN raw materials due to strong biotechnology capabilities, mature nutritional ingredient supply chains, and competitive production costs. China has become a major global supply center, supported by companies specializing in enzymatic production and high-purity NMN manufacturing. Japan maintains an important position through early commercialization and advanced biotechnology expertise. Europe and North America are mainly characterized by high-value downstream markets, premium supplement brands, and increasing consumer demand for longevity products.Competitive Landscape Analysis
The global NMN raw material market is characterized by a combination of specialized biotechnology manufacturers and downstream longevity brands. Chinese suppliers such as Bontac, EffePharm, Kingdomway, and GeneHarbor represent important participants in NMN ingredient manufacturing, particularly in high-purity production and commercial supply. Japanese companies such as ZaaZ Inc. contribute to the development of Japan-origin NMN supply chains. Companies including Herbalmax, Genex Formulas, and Mirai Lab Bioscience are mainly positioned in downstream supplement commercialization rather than upstream raw material manufacturing. Future competition will focus on production technology, purity consistency, regulatory compliance, cost efficiency, and global customer partnerships.Report Scope
This report studies the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) production, demand, key manufacturers, and key regions.This report is a detailed and comprehensive analysis of the world market for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) total production and demand, 2021-2032, (Tons)
- Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) total production value, 2021-2032, (USD Million)
- Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
- Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) consumption by region & country, CAGR, 2021-2032 & (Tons)
- U.S. VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) domestic production, consumption, key domestic manufacturers and share
- Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
- Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
- Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market, Segmentation by Type:
- Purity ≥98%
- Purity <98%
Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market, Segmentation by Manufacturing Process:
- Chemical Synthesis
- Enzyme Catalysis
- Fermentation
Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market, Segmentation by Chemical Structure:
- ?-NMN (?-Nicotinamide Mononucleotide)
- ?-NMN (?-Nicotinamide Mononucleotide)
Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market, Segmentation by Application:
- Dietary Supplements
- Functional Foods
- Beauty and Anti-aging
- Others
Companies Profiled:
- Herbalmax
- Genex Formulas
- Maac10 Formulas
- GeneHarbor
- Bontac
- CELFULL
- Zhongsheng Pharmaceutical
- Mirailab Bioscience
- EffePharm
- Kingdomway
- ?Yaben Chemical?
- ZaaZ Inc.
Key Questions Answered:
1. How big is the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market?2. What is the demand of the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market?
3. What is the year over year growth of the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market?
4. What is the production and production value of the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market?
5. Who are the key producers in the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Introduction
1.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Supply & Forecast
1.2.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (2021 & 2025 & 2032)
1.2.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.2.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Pricing Trends (2021-2032)
1.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Region (Based on Production Site)
1.3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region (2021-2032)
1.3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Region (2021-2032)
1.3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Region (2021-2032)
1.3.4 North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.3.5 Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.3.6 China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.3.7 Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.3.8 India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Major Market Trends
2 DEMAND SUMMARY
2.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Demand (2021-2032)
2.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region
2.2.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region (2021-2026)
2.2.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Forecast by Region (2027-2032)
2.3 United States Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.4 China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.5 Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.6 Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.7 South Korea Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.8 ASEAN Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.9 India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturer (2021-2026)
3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturer (2021-2026)
3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturer (2021-2026)
3.4 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) in 2025
3.5.3 Global Concentration Ratios (CR8) for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) in 2025
3.6 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Overall Company Footprint Analysis
3.6.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Region Footprint
3.6.2 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Company Product Type Footprint
3.6.3 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Comparison
4.1.1 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Comparison
4.2.1 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Comparison
4.3.1 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2026)
4.5 China Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers and Market Share
4.5.1 China Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (2021-2026)
4.5.3 China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2026)
4.6 Rest of World Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Purity ≥98%
5.2.2 Purity <98%
5.3 Market Segment by Type
5.3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Type (2021-2032)
5.3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type (2021-2032)
5.3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MANUFACTURING PROCESS
6.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Size Overview by Manufacturing Process: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Manufacturing Process
6.2.1 Chemical Synthesis
6.2.2 Enzyme Catalysis
6.2.3 Fermentation
6.3 Market Segment by Manufacturing Process
6.3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturing Process (2021-2032)
6.3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturing Process (2021-2032)
6.3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturing Process (2021-2032)
7 MARKET ANALYSIS BY CHEMICAL STRUCTURE
7.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Size Overview by Chemical Structure: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Chemical Structure
7.2.1 ?-NMN (?-Nicotinamide Mononucleotide)
7.2.2 ?-NMN (?-Nicotinamide Mononucleotide)
7.3 Market Segment by Chemical Structure
7.3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Chemical Structure (2021-2032)
7.3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Chemical Structure (2021-2032)
7.3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Chemical Structure (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Dietary Supplements
8.2.2 Functional Foods
8.2.3 Beauty and Anti-aging
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Application (2021-2032)
8.3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application (2021-2032)
8.3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Herbalmax
9.1.1 Herbalmax Details
9.1.2 Herbalmax Major Business
9.1.3 Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.1.4 Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Herbalmax Recent Developments/Updates
9.1.6 Herbalmax Competitive Strengths & Weaknesses
9.2 Genex Formulas
9.2.1 Genex Formulas Details
9.2.2 Genex Formulas Major Business
9.2.3 Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.2.4 Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Genex Formulas Recent Developments/Updates
9.2.6 Genex Formulas Competitive Strengths & Weaknesses
9.3 Maac10 Formulas
9.3.1 Maac10 Formulas Details
9.3.2 Maac10 Formulas Major Business
9.3.3 Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.3.4 Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Maac10 Formulas Recent Developments/Updates
9.3.6 Maac10 Formulas Competitive Strengths & Weaknesses
9.4 GeneHarbor
9.4.1 GeneHarbor Details
9.4.2 GeneHarbor Major Business
9.4.3 GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.4.4 GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 GeneHarbor Recent Developments/Updates
9.4.6 GeneHarbor Competitive Strengths & Weaknesses
9.5 Bontac
9.5.1 Bontac Details
9.5.2 Bontac Major Business
9.5.3 Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.5.4 Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Bontac Recent Developments/Updates
9.5.6 Bontac Competitive Strengths & Weaknesses
9.6 CELFULL
9.6.1 CELFULL Details
9.6.2 CELFULL Major Business
9.6.3 CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.6.4 CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 CELFULL Recent Developments/Updates
9.6.6 CELFULL Competitive Strengths & Weaknesses
9.7 Zhongsheng Pharmaceutical
9.7.1 Zhongsheng Pharmaceutical Details
9.7.2 Zhongsheng Pharmaceutical Major Business
9.7.3 Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.7.4 Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Zhongsheng Pharmaceutical Recent Developments/Updates
9.7.6 Zhongsheng Pharmaceutical Competitive Strengths & Weaknesses
9.8 Mirailab Bioscience
9.8.1 Mirailab Bioscience Details
9.8.2 Mirailab Bioscience Major Business
9.8.3 Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.8.4 Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Mirailab Bioscience Recent Developments/Updates
9.8.6 Mirailab Bioscience Competitive Strengths & Weaknesses
9.9 EffePharm
9.9.1 EffePharm Details
9.9.2 EffePharm Major Business
9.9.3 EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.9.4 EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 EffePharm Recent Developments/Updates
9.9.6 EffePharm Competitive Strengths & Weaknesses
9.10 Kingdomway
9.10.1 Kingdomway Details
9.10.2 Kingdomway Major Business
9.10.3 Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.10.4 Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Kingdomway Recent Developments/Updates
9.10.6 Kingdomway Competitive Strengths & Weaknesses
9.11 ?Yaben Chemical?
9.11.1 ?Yaben Chemical? Details
9.11.2 ?Yaben Chemical? Major Business
9.11.3 ?Yaben Chemical? Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.11.4 ?Yaben Chemical? Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 ?Yaben Chemical? Recent Developments/Updates
9.11.6 ?Yaben Chemical? Competitive Strengths & Weaknesses
9.12 ZaaZ Inc.
9.12.1 ZaaZ Inc. Details
9.12.2 ZaaZ Inc. Major Business
9.12.3 ZaaZ Inc. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.12.4 ZaaZ Inc. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 ZaaZ Inc. Recent Developments/Updates
9.12.6 ZaaZ Inc. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Chain
10.2 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Upstream Analysis
10.2.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Core Raw Materials
10.2.2 Main Manufacturers of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Mode
10.6 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Procurement Model
10.7 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Sales Model and Sales Channels
10.7.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Sales Model
10.7.2 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Introduction
1.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Supply & Forecast
1.2.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (2021 & 2025 & 2032)
1.2.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.2.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Pricing Trends (2021-2032)
1.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Region (Based on Production Site)
1.3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region (2021-2032)
1.3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Region (2021-2032)
1.3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Region (2021-2032)
1.3.4 North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.3.5 Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.3.6 China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.3.7 Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.3.8 India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Major Market Trends
2 DEMAND SUMMARY
2.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Demand (2021-2032)
2.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region
2.2.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region (2021-2026)
2.2.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Forecast by Region (2027-2032)
2.3 United States Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.4 China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.5 Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.6 Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.7 South Korea Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.8 ASEAN Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
2.9 India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturer (2021-2026)
3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturer (2021-2026)
3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturer (2021-2026)
3.4 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) in 2025
3.5.3 Global Concentration Ratios (CR8) for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) in 2025
3.6 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Overall Company Footprint Analysis
3.6.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Region Footprint
3.6.2 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Company Product Type Footprint
3.6.3 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Comparison
4.1.1 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Comparison
4.2.1 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Comparison
4.3.1 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2026)
4.5 China Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers and Market Share
4.5.1 China Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (2021-2026)
4.5.3 China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2026)
4.6 Rest of World Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Purity ≥98%
5.2.2 Purity <98%
5.3 Market Segment by Type
5.3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Type (2021-2032)
5.3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type (2021-2032)
5.3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MANUFACTURING PROCESS
6.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Size Overview by Manufacturing Process: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Manufacturing Process
6.2.1 Chemical Synthesis
6.2.2 Enzyme Catalysis
6.2.3 Fermentation
6.3 Market Segment by Manufacturing Process
6.3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturing Process (2021-2032)
6.3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturing Process (2021-2032)
6.3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturing Process (2021-2032)
7 MARKET ANALYSIS BY CHEMICAL STRUCTURE
7.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Size Overview by Chemical Structure: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Chemical Structure
7.2.1 ?-NMN (?-Nicotinamide Mononucleotide)
7.2.2 ?-NMN (?-Nicotinamide Mononucleotide)
7.3 Market Segment by Chemical Structure
7.3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Chemical Structure (2021-2032)
7.3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Chemical Structure (2021-2032)
7.3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Chemical Structure (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Dietary Supplements
8.2.2 Functional Foods
8.2.3 Beauty and Anti-aging
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Application (2021-2032)
8.3.2 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application (2021-2032)
8.3.3 World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Herbalmax
9.1.1 Herbalmax Details
9.1.2 Herbalmax Major Business
9.1.3 Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.1.4 Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Herbalmax Recent Developments/Updates
9.1.6 Herbalmax Competitive Strengths & Weaknesses
9.2 Genex Formulas
9.2.1 Genex Formulas Details
9.2.2 Genex Formulas Major Business
9.2.3 Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.2.4 Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Genex Formulas Recent Developments/Updates
9.2.6 Genex Formulas Competitive Strengths & Weaknesses
9.3 Maac10 Formulas
9.3.1 Maac10 Formulas Details
9.3.2 Maac10 Formulas Major Business
9.3.3 Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.3.4 Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Maac10 Formulas Recent Developments/Updates
9.3.6 Maac10 Formulas Competitive Strengths & Weaknesses
9.4 GeneHarbor
9.4.1 GeneHarbor Details
9.4.2 GeneHarbor Major Business
9.4.3 GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.4.4 GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 GeneHarbor Recent Developments/Updates
9.4.6 GeneHarbor Competitive Strengths & Weaknesses
9.5 Bontac
9.5.1 Bontac Details
9.5.2 Bontac Major Business
9.5.3 Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.5.4 Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Bontac Recent Developments/Updates
9.5.6 Bontac Competitive Strengths & Weaknesses
9.6 CELFULL
9.6.1 CELFULL Details
9.6.2 CELFULL Major Business
9.6.3 CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.6.4 CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 CELFULL Recent Developments/Updates
9.6.6 CELFULL Competitive Strengths & Weaknesses
9.7 Zhongsheng Pharmaceutical
9.7.1 Zhongsheng Pharmaceutical Details
9.7.2 Zhongsheng Pharmaceutical Major Business
9.7.3 Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.7.4 Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Zhongsheng Pharmaceutical Recent Developments/Updates
9.7.6 Zhongsheng Pharmaceutical Competitive Strengths & Weaknesses
9.8 Mirailab Bioscience
9.8.1 Mirailab Bioscience Details
9.8.2 Mirailab Bioscience Major Business
9.8.3 Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.8.4 Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Mirailab Bioscience Recent Developments/Updates
9.8.6 Mirailab Bioscience Competitive Strengths & Weaknesses
9.9 EffePharm
9.9.1 EffePharm Details
9.9.2 EffePharm Major Business
9.9.3 EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.9.4 EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 EffePharm Recent Developments/Updates
9.9.6 EffePharm Competitive Strengths & Weaknesses
9.10 Kingdomway
9.10.1 Kingdomway Details
9.10.2 Kingdomway Major Business
9.10.3 Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.10.4 Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Kingdomway Recent Developments/Updates
9.10.6 Kingdomway Competitive Strengths & Weaknesses
9.11 ?Yaben Chemical?
9.11.1 ?Yaben Chemical? Details
9.11.2 ?Yaben Chemical? Major Business
9.11.3 ?Yaben Chemical? Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.11.4 ?Yaben Chemical? Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 ?Yaben Chemical? Recent Developments/Updates
9.11.6 ?Yaben Chemical? Competitive Strengths & Weaknesses
9.12 ZaaZ Inc.
9.12.1 ZaaZ Inc. Details
9.12.2 ZaaZ Inc. Major Business
9.12.3 ZaaZ Inc. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
9.12.4 ZaaZ Inc. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 ZaaZ Inc. Recent Developments/Updates
9.12.6 ZaaZ Inc. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Chain
10.2 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Upstream Analysis
10.2.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Core Raw Materials
10.2.2 Main Manufacturers of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Mode
10.6 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Procurement Model
10.7 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Sales Model and Sales Channels
10.7.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Sales Model
10.7.2 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Region (2021-2026)
Table 5. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Region (2027-2032)
Table 6. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Region (2021-2026) & (Tons)
Table 7. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Region (2027-2032) & (Tons)
Table 8. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Region (2021-2026)
Table 9. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Region (2027-2032)
Table 10. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Region (2021-2026) & (US$/Ton)
Table 11. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Region (2027-2032) & (US$/Ton)
Table 12. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Major Market Trends
Table 13. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region (2021-2026) & (Tons)
Table 15. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Producers in 2025
Table 18. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Producers in 2025
Table 20. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 21. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Evaluation Quadrant
Table 22. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Site of Key Manufacturer
Table 24. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Company Product Type Footprint
Table 25. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Company Product Application Footprint
Table 26. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Competitive Factors
Table 27. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) New Entrant and Capacity Expansion Plans
Table 28. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Mergers & Acquisitions Activity
Table 29. United States VS China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share (2021-2026)
Table 37. China Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share (2021-2026)
Table 42. Rest of World Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share (2021-2026)
Table 47. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Type (2021-2026) & (Tons)
Table 49. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Type (2027-2032) & (Tons)
Table 50. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Type (2021-2026) & (US$/Ton)
Table 53. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Type (2027-2032) & (US$/Ton)
Table 54. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Table 55. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturing Process (2021-2026) & (Tons)
Table 56. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturing Process (2027-2032) & (Tons)
Table 57. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturing Process (2021-2026) & (USD Million)
Table 58. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturing Process (2027-2032) & (USD Million)
Table 59. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturing Process (2021-2026) & (US$/Ton)
Table 60. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturing Process (2027-2032) & (US$/Ton)
Table 61. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Chemical Structure, (USD Million), 2021 & 2025 & 2032
Table 62. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Chemical Structure (2021-2026) & (Tons)
Table 63. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Chemical Structure (2027-2032) & (Tons)
Table 64. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Chemical Structure (2021-2026) & (USD Million)
Table 65. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Chemical Structure (2027-2032) & (USD Million)
Table 66. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Chemical Structure (2021-2026) & (US$/Ton)
Table 67. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Chemical Structure (2027-2032) & (US$/Ton)
Table 68. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Application (2021-2026) & (Tons)
Table 70. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Application (2027-2032) & (Tons)
Table 71. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Application (2021-2026) & (US$/Ton)
Table 74. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Application (2027-2032) & (US$/Ton)
Table 75. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 76. Herbalmax Major Business
Table 77. Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 78. Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Herbalmax Recent Developments/Updates
Table 80. Herbalmax Competitive Strengths & Weaknesses
Table 81. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 82. Genex Formulas Major Business
Table 83. Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 84. Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Genex Formulas Recent Developments/Updates
Table 86. Genex Formulas Competitive Strengths & Weaknesses
Table 87. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 88. Maac10 Formulas Major Business
Table 89. Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 90. Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Maac10 Formulas Recent Developments/Updates
Table 92. Maac10 Formulas Competitive Strengths & Weaknesses
Table 93. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 94. GeneHarbor Major Business
Table 95. GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 96. GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. GeneHarbor Recent Developments/Updates
Table 98. GeneHarbor Competitive Strengths & Weaknesses
Table 99. Bontac Basic Information, Manufacturing Base and Competitors
Table 100. Bontac Major Business
Table 101. Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 102. Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Bontac Recent Developments/Updates
Table 104. Bontac Competitive Strengths & Weaknesses
Table 105. CELFULL Basic Information, Manufacturing Base and Competitors
Table 106. CELFULL Major Business
Table 107. CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 108. CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. CELFULL Recent Developments/Updates
Table 110. CELFULL Competitive Strengths & Weaknesses
Table 111. Zhongsheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Zhongsheng Pharmaceutical Major Business
Table 113. Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 114. Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Zhongsheng Pharmaceutical Recent Developments/Updates
Table 116. Zhongsheng Pharmaceutical Competitive Strengths & Weaknesses
Table 117. Mirailab Bioscience Basic Information, Manufacturing Base and Competitors
Table 118. Mirailab Bioscience Major Business
Table 119. Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 120. Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Mirailab Bioscience Recent Developments/Updates
Table 122. Mirailab Bioscience Competitive Strengths & Weaknesses
Table 123. EffePharm Basic Information, Manufacturing Base and Competitors
Table 124. EffePharm Major Business
Table 125. EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 126. EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. EffePharm Recent Developments/Updates
Table 128. EffePharm Competitive Strengths & Weaknesses
Table 129. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 130. Kingdomway Major Business
Table 131. Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 132. Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Kingdomway Recent Developments/Updates
Table 134. Kingdomway Competitive Strengths & Weaknesses
Table 135. ?Yaben Chemical? Basic Information, Manufacturing Base and Competitors
Table 136. ?Yaben Chemical? Major Business
Table 137. ?Yaben Chemical? Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 138. ?Yaben Chemical? Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. ?Yaben Chemical? Recent Developments/Updates
Table 140. ?Yaben Chemical? Competitive Strengths & Weaknesses
Table 141. ZaaZ Inc. Basic Information, Manufacturing Base and Competitors
Table 142. ZaaZ Inc. Major Business
Table 143. ZaaZ Inc. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 144. ZaaZ Inc. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. ZaaZ Inc. Recent Developments/Updates
Table 146. ZaaZ Inc. Competitive Strengths & Weaknesses
Table 147. Global Key Players of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Upstream (Raw Materials)
Table 148. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Typical Customers
Table 149. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Typical Distributors
Table 1. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Region (2021-2026)
Table 5. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Region (2027-2032)
Table 6. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Region (2021-2026) & (Tons)
Table 7. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Region (2027-2032) & (Tons)
Table 8. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Region (2021-2026)
Table 9. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Region (2027-2032)
Table 10. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Region (2021-2026) & (US$/Ton)
Table 11. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Region (2027-2032) & (US$/Ton)
Table 12. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Major Market Trends
Table 13. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region (2021-2026) & (Tons)
Table 15. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Producers in 2025
Table 18. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Producers in 2025
Table 20. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 21. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Evaluation Quadrant
Table 22. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Site of Key Manufacturer
Table 24. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Company Product Type Footprint
Table 25. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market: Company Product Application Footprint
Table 26. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Competitive Factors
Table 27. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) New Entrant and Capacity Expansion Plans
Table 28. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Mergers & Acquisitions Activity
Table 29. United States VS China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share (2021-2026)
Table 37. China Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share (2021-2026)
Table 42. Rest of World Based Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share (2021-2026)
Table 47. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Type (2021-2026) & (Tons)
Table 49. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Type (2027-2032) & (Tons)
Table 50. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Type (2021-2026) & (US$/Ton)
Table 53. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Type (2027-2032) & (US$/Ton)
Table 54. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Table 55. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturing Process (2021-2026) & (Tons)
Table 56. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturing Process (2027-2032) & (Tons)
Table 57. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturing Process (2021-2026) & (USD Million)
Table 58. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturing Process (2027-2032) & (USD Million)
Table 59. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturing Process (2021-2026) & (US$/Ton)
Table 60. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturing Process (2027-2032) & (US$/Ton)
Table 61. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Chemical Structure, (USD Million), 2021 & 2025 & 2032
Table 62. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Chemical Structure (2021-2026) & (Tons)
Table 63. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Chemical Structure (2027-2032) & (Tons)
Table 64. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Chemical Structure (2021-2026) & (USD Million)
Table 65. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Chemical Structure (2027-2032) & (USD Million)
Table 66. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Chemical Structure (2021-2026) & (US$/Ton)
Table 67. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Chemical Structure (2027-2032) & (US$/Ton)
Table 68. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Application (2021-2026) & (Tons)
Table 70. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Application (2027-2032) & (Tons)
Table 71. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Application (2021-2026) & (US$/Ton)
Table 74. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Application (2027-2032) & (US$/Ton)
Table 75. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 76. Herbalmax Major Business
Table 77. Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 78. Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Herbalmax Recent Developments/Updates
Table 80. Herbalmax Competitive Strengths & Weaknesses
Table 81. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 82. Genex Formulas Major Business
Table 83. Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 84. Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Genex Formulas Recent Developments/Updates
Table 86. Genex Formulas Competitive Strengths & Weaknesses
Table 87. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 88. Maac10 Formulas Major Business
Table 89. Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 90. Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Maac10 Formulas Recent Developments/Updates
Table 92. Maac10 Formulas Competitive Strengths & Weaknesses
Table 93. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 94. GeneHarbor Major Business
Table 95. GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 96. GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. GeneHarbor Recent Developments/Updates
Table 98. GeneHarbor Competitive Strengths & Weaknesses
Table 99. Bontac Basic Information, Manufacturing Base and Competitors
Table 100. Bontac Major Business
Table 101. Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 102. Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Bontac Recent Developments/Updates
Table 104. Bontac Competitive Strengths & Weaknesses
Table 105. CELFULL Basic Information, Manufacturing Base and Competitors
Table 106. CELFULL Major Business
Table 107. CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 108. CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. CELFULL Recent Developments/Updates
Table 110. CELFULL Competitive Strengths & Weaknesses
Table 111. Zhongsheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Zhongsheng Pharmaceutical Major Business
Table 113. Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 114. Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Zhongsheng Pharmaceutical Recent Developments/Updates
Table 116. Zhongsheng Pharmaceutical Competitive Strengths & Weaknesses
Table 117. Mirailab Bioscience Basic Information, Manufacturing Base and Competitors
Table 118. Mirailab Bioscience Major Business
Table 119. Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 120. Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Mirailab Bioscience Recent Developments/Updates
Table 122. Mirailab Bioscience Competitive Strengths & Weaknesses
Table 123. EffePharm Basic Information, Manufacturing Base and Competitors
Table 124. EffePharm Major Business
Table 125. EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 126. EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. EffePharm Recent Developments/Updates
Table 128. EffePharm Competitive Strengths & Weaknesses
Table 129. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 130. Kingdomway Major Business
Table 131. Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 132. Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Kingdomway Recent Developments/Updates
Table 134. Kingdomway Competitive Strengths & Weaknesses
Table 135. ?Yaben Chemical? Basic Information, Manufacturing Base and Competitors
Table 136. ?Yaben Chemical? Major Business
Table 137. ?Yaben Chemical? Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 138. ?Yaben Chemical? Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. ?Yaben Chemical? Recent Developments/Updates
Table 140. ?Yaben Chemical? Competitive Strengths & Weaknesses
Table 141. ZaaZ Inc. Basic Information, Manufacturing Base and Competitors
Table 142. ZaaZ Inc. Major Business
Table 143. ZaaZ Inc. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product and Services
Table 144. ZaaZ Inc. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. ZaaZ Inc. Recent Developments/Updates
Table 146. ZaaZ Inc. Competitive Strengths & Weaknesses
Table 147. Global Key Players of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Upstream (Raw Materials)
Table 148. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Typical Customers
Table 149. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Typical Distributors
LIST OF FIGURES
Figure 1. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Picture
Figure 2. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 5. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price (2021-2032) & (US$/Ton)
Figure 6. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Region (2021-2032)
Figure 7. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Region (2021-2032)
Figure 8. North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 9. Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 10. China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 11. Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 12. India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 13. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 16. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share by Region (2021-2032)
Figure 17. United States Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 18. China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 19. Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 20. Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 21. South Korea Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 22. ASEAN Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 23. India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 24. Producer Shipments of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Markets in 2025
Figure 27. United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share 2025
Figure 31. China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share 2025
Figure 33. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Type in 2025
Figure 35. Purity ≥98%
Figure 36. Purity <98%
Figure 37. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Type (2021-2032)
Figure 38. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Type (2021-2032)
Figure 39. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Type (2021-2032) & (US$/Ton)
Figure 40. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Figure 41. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Manufacturing Process in 2025
Figure 42. Chemical Synthesis
Figure 43. Enzyme Catalysis
Figure 44. Fermentation
Figure 45. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Manufacturing Process (2021-2032)
Figure 46. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Manufacturing Process (2021-2032)
Figure 47. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturing Process (2021-2032) & (US$/Ton)
Figure 48. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Chemical Structure, (USD Million), 2021 & 2025 & 2032
Figure 49. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Chemical Structure in 2025
Figure 50. ?-NMN (?-Nicotinamide Mononucleotide)
Figure 51. ?-NMN (?-Nicotinamide Mononucleotide)
Figure 52. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Chemical Structure (2021-2032)
Figure 53. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Chemical Structure (2021-2032)
Figure 54. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Chemical Structure (2021-2032) & (US$/Ton)
Figure 55. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Application in 2025
Figure 57. Dietary Supplements
Figure 58. Functional Foods
Figure 59. Beauty and Anti-aging
Figure 60. Others
Figure 61. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Application (2021-2032)
Figure 62. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Application (2021-2032)
Figure 63. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Application (2021-2032) & (US$/Ton)
Figure 64. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Chain
Figure 65. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Procurement Model
Figure 66. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Sales Model
Figure 67. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Picture
Figure 2. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 5. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price (2021-2032) & (US$/Ton)
Figure 6. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Region (2021-2032)
Figure 7. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Region (2021-2032)
Figure 8. North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 9. Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 10. China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 11. Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 12. India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (2021-2032) & (Tons)
Figure 13. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 16. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share by Region (2021-2032)
Figure 17. United States Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 18. China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 19. Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 20. Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 21. South Korea Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 22. ASEAN Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 23. India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption (2021-2032) & (Tons)
Figure 24. Producer Shipments of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Markets in 2025
Figure 27. United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share 2025
Figure 31. China Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share 2025
Figure 33. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Type in 2025
Figure 35. Purity ≥98%
Figure 36. Purity <98%
Figure 37. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Type (2021-2032)
Figure 38. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Type (2021-2032)
Figure 39. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Type (2021-2032) & (US$/Ton)
Figure 40. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Figure 41. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Manufacturing Process in 2025
Figure 42. Chemical Synthesis
Figure 43. Enzyme Catalysis
Figure 44. Fermentation
Figure 45. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Manufacturing Process (2021-2032)
Figure 46. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Manufacturing Process (2021-2032)
Figure 47. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturing Process (2021-2032) & (US$/Ton)
Figure 48. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Chemical Structure, (USD Million), 2021 & 2025 & 2032
Figure 49. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Chemical Structure in 2025
Figure 50. ?-NMN (?-Nicotinamide Mononucleotide)
Figure 51. ?-NMN (?-Nicotinamide Mononucleotide)
Figure 52. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Chemical Structure (2021-2032)
Figure 53. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Chemical Structure (2021-2032)
Figure 54. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Chemical Structure (2021-2032) & (US$/Ton)
Figure 55. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Application in 2025
Figure 57. Dietary Supplements
Figure 58. Functional Foods
Figure 59. Beauty and Anti-aging
Figure 60. Others
Figure 61. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Application (2021-2032)
Figure 62. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Application (2021-2032)
Figure 63. World Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Application (2021-2032) & (US$/Ton)
Figure 64. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Chain
Figure 65. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Procurement Model
Figure 66. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Sales Model
Figure 67. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
